EP3893878A4 - Dispersions solides amorphes - Google Patents
Dispersions solides amorphes Download PDFInfo
- Publication number
- EP3893878A4 EP3893878A4 EP19897052.7A EP19897052A EP3893878A4 EP 3893878 A4 EP3893878 A4 EP 3893878A4 EP 19897052 A EP19897052 A EP 19897052A EP 3893878 A4 EP3893878 A4 EP 3893878A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- amorphous solid
- solid dispersions
- dispersions
- amorphous
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862779930P | 2018-12-14 | 2018-12-14 | |
PCT/US2019/066247 WO2020123952A1 (fr) | 2018-12-14 | 2019-12-13 | Dispersions solides amorphes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3893878A1 EP3893878A1 (fr) | 2021-10-20 |
EP3893878A4 true EP3893878A4 (fr) | 2022-08-17 |
Family
ID=71077112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19897052.7A Pending EP3893878A4 (fr) | 2018-12-14 | 2019-12-13 | Dispersions solides amorphes |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3893878A4 (fr) |
JP (1) | JP2022512239A (fr) |
KR (1) | KR20210103501A (fr) |
CN (1) | CN113473988A (fr) |
AU (1) | AU2019398451A1 (fr) |
CA (1) | CA3123085A1 (fr) |
IL (1) | IL283927A (fr) |
MX (1) | MX2021006886A (fr) |
WO (1) | WO2020123952A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112584837A (zh) * | 2018-08-31 | 2021-03-30 | 细胞内治疗公司 | 新方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018071233A1 (fr) * | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Dispersions solides amorphes |
WO2018189646A1 (fr) * | 2017-04-10 | 2018-10-18 | Dr. Reddy's Laboratories Limited | Forme amorphe et dispersions solides de p-tosylate de lumateperone |
WO2020047407A1 (fr) * | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Nouvelles méthodes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2901375T3 (es) * | 2016-08-09 | 2022-03-22 | Teva Pharmaceuticals Int Gmbh | Formas en estado sólido de sal de ditosilato de lumateperona |
WO2019102240A1 (fr) * | 2017-11-27 | 2019-05-31 | Egis Gyógyszergyár Zrt. | Procédé pour la fabrication de lumatépérone et de ses sels |
-
2019
- 2019-12-13 AU AU2019398451A patent/AU2019398451A1/en active Pending
- 2019-12-13 CA CA3123085A patent/CA3123085A1/fr active Pending
- 2019-12-13 MX MX2021006886A patent/MX2021006886A/es unknown
- 2019-12-13 CN CN201980092118.2A patent/CN113473988A/zh active Pending
- 2019-12-13 EP EP19897052.7A patent/EP3893878A4/fr active Pending
- 2019-12-13 KR KR1020217021918A patent/KR20210103501A/ko active Search and Examination
- 2019-12-13 WO PCT/US2019/066247 patent/WO2020123952A1/fr unknown
- 2019-12-13 JP JP2021533470A patent/JP2022512239A/ja active Pending
-
2021
- 2021-06-13 IL IL283927A patent/IL283927A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018071233A1 (fr) * | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Dispersions solides amorphes |
WO2018189646A1 (fr) * | 2017-04-10 | 2018-10-18 | Dr. Reddy's Laboratories Limited | Forme amorphe et dispersions solides de p-tosylate de lumateperone |
WO2020047407A1 (fr) * | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Nouvelles méthodes |
Non-Patent Citations (1)
Title |
---|
See also references of WO2020123952A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2022512239A (ja) | 2022-02-02 |
CA3123085A1 (fr) | 2020-06-18 |
IL283927A (en) | 2021-07-29 |
CN113473988A (zh) | 2021-10-01 |
EP3893878A1 (fr) | 2021-10-20 |
AU2019398451A1 (en) | 2021-07-15 |
KR20210103501A (ko) | 2021-08-23 |
WO2020123952A1 (fr) | 2020-06-18 |
MX2021006886A (es) | 2021-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3803740A4 (fr) | Protection de chaîne de blocs | |
EP3801265A4 (fr) | Débitmètre urinaire | |
EP3525763A4 (fr) | Dispersions solides amorphes | |
EP3763127A4 (fr) | Dst-7 rapide | |
EP3831012A4 (fr) | Chaîne de blocs bidirectionnelle | |
EP3784463A4 (fr) | Fluorosulfones | |
EP3486371B8 (fr) | Unité de commutation de rail | |
EP3721129A4 (fr) | Cryosphère | |
EP3769888A4 (fr) | Fraise cylindrique | |
EP3876716A4 (fr) | Support cryogénique | |
EP3820790A4 (fr) | Aide de poubelle | |
EP3840572A4 (fr) | Mangeoire accessible de manière sélective | |
EP3769389A4 (fr) | Chargeur de dispositif | |
IL283927A (en) | Amorphous solid dispersions | |
EP3812070A4 (fr) | Fraise à queue à rainurer | |
EP3738602A4 (fr) | Cytocide | |
AU2018101027A4 (en) | PadPay | |
EP3830662A4 (fr) | Dispositif de surveillance de plantes | |
EP3797079A4 (fr) | Revêtement cryogénique | |
EP3773733A4 (fr) | Métallo-liothyronine | |
AU2018904244A0 (en) | sparemate | |
AU2018903905A0 (en) | Accuglove | |
EP3865237A4 (fr) | Fraise en bout | |
AU2018903851A0 (en) | TrailerSafe | |
AU2018903743A0 (en) | Siron |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210702 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40052693 Country of ref document: HK |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031495000 Ipc: A61K0009140000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220715 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/00 20060101ALI20220711BHEP Ipc: A61P 1/00 20060101ALI20220711BHEP Ipc: C07D 471/16 20060101ALI20220711BHEP Ipc: A61K 31/4985 20060101ALI20220711BHEP Ipc: A61K 9/48 20060101ALI20220711BHEP Ipc: A61K 9/20 20060101ALI20220711BHEP Ipc: A61K 31/495 20060101ALI20220711BHEP Ipc: A61K 9/14 20060101AFI20220711BHEP |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230517 |